# P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

> **NCT07285096** · — · RECRUITING · sponsor: **Yueyue Li** · enrollment: 1730 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **OTHER:** Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures

## Key facts

- **NCT ID:** NCT07285096
- **Lead sponsor:** Yueyue Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 1730 (ESTIMATED)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07285096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07285096, "P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07285096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*